| abstract |
The present invention relates to substantially pure ENCLO metabolite.The present invention also relates to comprise the pharmaceutical composition of these metabolites and their purposes in treatment obstacle, described obstacle comprises: the cholesterol of secondary hypogonadism, type ii diabetes, rising, the triglyceride level of rising, become thin, lipodystrophy, women and male sterility, benign prostatauxe, prostate cancer, mammary cancer, ovarian cancer and carcinoma of endometrium. |